By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling.
Shailesh Vengurlekar
Advertisement
Shailesh Vengurlekar is senior vice-president, Quality and Regulatory Affairs, at LGM Pharma.
Articles by Shailesh Vengurlekar
Advertisement
Latest Updated Articles
Establishing a Framework for Reliable Pharma LabelingDecember 2nd 2023
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
2
PharmSci 360: Build the Device Into Dosage Form Development From Day One
3
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
4
Why Drug Shortages Average 5+ Years: PharmTech Explained
5